0001385508-18-000004.txt : 20180108 0001385508-18-000004.hdr.sgml : 20180108 20180108183424 ACCESSION NUMBER: 0001385508-18-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180104 FILED AS OF DATE: 20180108 DATE AS OF CHANGE: 20180108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Toole David D CENTRAL INDEX KEY: 0001491140 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38193 FILM NUMBER: 18517520 MAIL ADDRESS: STREET 1: 1640 MARENGO STREET CITY: LOS ANGELES STATE: CA ZIP: 90033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001385508 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 SANTA MONICA BOULEVARD STREET 2: SUITE 500 CITY: SANTA MONICA STATE: CA ZIP: 90401 BUSINESS PHONE: (310) 598-5410 MAIL ADDRESS: STREET 1: 201 SANTA MONICA BOULEVARD STREET 2: SUITE 500 CITY: SANTA MONICA STATE: CA ZIP: 90401 FORMER COMPANY: FORMER CONFORMED NAME: Lightlake Therapeutics Inc. DATE OF NAME CHANGE: 20091009 FORMER COMPANY: FORMER CONFORMED NAME: Madrona Ventures, Inc. DATE OF NAME CHANGE: 20070108 4 1 wf-form4_151545445086053.xml FORM 4 X0306 4 2018-01-04 0 0001385508 OPIANT PHARMACEUTICALS, INC. OPNT 0001491140 O'Toole David D C/O OPIANT PHARMACEUTICALS, INC. 201 SANTA MONICA BOULEVARD, SUITE 500 SANTA MONICA CA 90401 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 24.84 2018-01-04 4 A 0 13200 0 A 2028-01-03 Common Stock 13200.0 13200 D On January 4, 2018, the reporting person was granted an option to purchase 13,200 shares of common stock. The option vests as follows: Twenty-five percent (25%) of the shares of common stock underlying the option shall vest on the one-year anniversary of the date of grant, and 2.083% of the shares of common stock underlying the option shall vest monthly thereafter, becoming fully vested on the four-year anniversary of the date of grant. /s/ David D. O'Toole 2018-01-08